Skip to main content

Advertisement

Log in

Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

To investigate the impact of a primary para-aortic lymphadenectomy (PAL) in locally advanced cervical cancer patients receiving definitive chemoradiation, we reviewed the clinical records of consecutive patients treated in our Institution and receiving an external beam irradiation followed with an image-guided adaptive brachytherapy for a locally advanced cervical cancer. We examined the impact of performing a primary PAL as part of primary staging for guiding irradiation fields in patients without extra-pelvic PET uptake. The outcome of patients presenting para-aortic lymph node uptake (PALNU) was also examined. 186 patients were identified. Median follow-up was 44.4 months. Patients receiving a primary PAL (PAL group) and those who received upfront pelvic chemoradiation (no-PAL group) did not significantly differ for loco-regional failures. Survival without distant failure (DFFS), including para-aortic relapses, was at 3 years 87 % (95 % CI 84–90 %) in PAL group, 67 % (95 % CI 59–85 %) in the no-PAL group and 44 % (95 % CI 32–66 %) in the PALNU group (p = 0.04 for comparison between PAL and no-PAL groups). In a multivariate model including para-aortic lymphadenectomy, pelvic nodal uptake and high-risk clinical target volume as adjustment variables, a para-aortic lymphadenectomy was significant for DFS (HR = 0.47, 95 % CI 0.26–0.84, p = 0.01). Although confounding factors could account for these retrospective results, a primary PAL with tailored irradiation fields based on para-aortic histological findings seems to be associated with a better control for distant metastases. A randomized trial is testing the benefit of this strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Potter R, Georg P, Dimopoulos JC et al (2011) Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 100:116–123

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mazeron R, Gilmore J, Dumas I et al (2013) Adaptive 3D image guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer. Oncologist 18:415–422

    Article  PubMed  PubMed Central  Google Scholar 

  3. Pötter R, Dimopoulos J, Georg P et al (2007) Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83:148–155

    Article  PubMed  Google Scholar 

  4. Dimopoulos JC, Potter R, Lang S et al (2009) Dose-effect relationship for local control of cervical cancer by magnetic resonance image guided brachytherapy. Radiother Oncol 93:311–315

    Article  PubMed  Google Scholar 

  5. Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K (2013) MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a nordic perspective. Acta Oncol 52:1510–1519

    Article  CAS  PubMed  Google Scholar 

  6. Nomden CN, de Leeuw AA, Roesink JM et al (2013) Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience. Radiother Oncol 107:69–74

    Article  PubMed  Google Scholar 

  7. Mazeron R, Castelnau-Marchand P, Dumas I et al (2015) Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy. Radiother Oncol 114:257–263

    Article  PubMed  Google Scholar 

  8. Chargari C, Magné N, Dumas I et al (2009) Physics and clinical contribution with MRI-based pulsed dose rate brachytherapy in patients with cervix carcinoma. Int J Radiat Oncol Biol Phys 74:133–139

    Article  PubMed  Google Scholar 

  9. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magné N (2010) MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 96:161–165

    Article  PubMed  Google Scholar 

  10. Charra-Brunaud C, Harter V, Delannes M et al (2012) Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 103:305–313

    Article  PubMed  Google Scholar 

  11. Schmid MP, Franckena M, Kirchheiner K et al (2014) Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy. Gynecol Oncol 133:256–262

    Article  CAS  PubMed  Google Scholar 

  12. Haie-Meder C, Mazeron R, Magné N (2010) Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers. Radiother Oncol 96:351–355

    Article  PubMed  Google Scholar 

  13. Uzan C, Souadka A, Gouy S et al (2011) Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area. Oncologist 16:1021–1027

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gouy S, Morice P, Narducci F et al (2012) Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol 13:212–220

    Article  Google Scholar 

  15. Magné N, Chargari C, SanFilippo N, Messai T, Gerbaulet A, Haie-Meder C (2009) Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecological malignancies. Brachytherapy 9:274–277

    Article  Google Scholar 

  16. Pötter R, Haie-Meder C, Van Limbergen E et al (2006) Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78:67–77

    Article  PubMed  Google Scholar 

  17. Haie-Meder C, Pötter R, Van Limbergen E et al (2005) Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74:235–245

    Article  PubMed  Google Scholar 

  18. Morice P, Rouanet P, Rey A et al (2012) Results of the GYNECO02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer. Oncologist 17:64–71

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Eifel PJ, Winter K, Morris M et al (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22:872–880

    Article  PubMed  Google Scholar 

  20. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration (2008) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26:5802–5812

    Article  CAS  PubMed Central  Google Scholar 

  21. Park SG, Kim JH, Oh YK et al (2014) Is prophylactic irradiation to para-aortic lymph nodes in locally advanced cervical cancer necessary? Cancer Res Treat 46:374–382

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Jung J, Park G, Kim YS (2014) Definitive extended-field intensity-modulated radiotherapy with chemotherapy for cervical cancer with para-aortic nodal metastasis. Anticancer Res 34:4361–4366

    PubMed  Google Scholar 

  23. Liang JA, Chen SW, Hung YC et al (2014) Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes. Int J Gynecol Cancer 24:901–907

    Article  PubMed  Google Scholar 

  24. Zhang G, Fu C, Zhang Y et al (2012) Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution. Int J Gynecol Cancer 22:1220–1225

    Article  PubMed  Google Scholar 

  25. Gouy S, Morice P, Narducci F et al (2013) Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol 31:3026–3033

    Article  PubMed  Google Scholar 

  26. Kang S, Kim SK, Chung DC et al (2010) Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis. J Nucl Med 51:360–367

    Article  PubMed  Google Scholar 

  27. Loft A, Berthelsen AK, Roed H et al (2007) The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 106:29–34

    Article  PubMed  Google Scholar 

  28. Choi HJ, Roh JW, Seo SS et al (2006) Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 106:914–922

    Article  PubMed  Google Scholar 

  29. Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R (2008) Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer 112:1954–1963

    Article  PubMed  Google Scholar 

  30. Vigliotti AP, Wen BC, Hussey DH et al (1992) Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes. Int J Radiat Oncol Biol Phys 23:501–509

    Article  CAS  PubMed  Google Scholar 

  31. Varia MA, Bundy BN, Deppe G et al (1998) Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 42:1015–1023

    Article  CAS  PubMed  Google Scholar 

  32. Lee JY, Kim Y, Lee TJ, et al. Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer. J Gynecol Oncol in press

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cyrus Chargari.

Ethics declarations

Conflict of interest

The authors report no financial or non-financial conflict of interest relative to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chargari, C., Mazeron, R., Dunant, A. et al. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy. Clin Exp Metastasis 33, 775–785 (2016). https://doi.org/10.1007/s10585-016-9817-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-016-9817-7

Keywords

Navigation